Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium polycarbophil tablets for IBS-D
CTR20230565Phase 3Completed
- Sponsor
- Zhejiang Lukang Pharmaceutical
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcium polycarbophil in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Zhejiang Lukang Pharmaceutical. Started May 2023; status: completed.
02
Drugs
calcium polycarbophil
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20230565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230565.